Cargando…
Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins
We believe this is the first study to investigate associations between blood metabolites and neocortical amyloid burden (NAB) in the search for a blood-based biomarker for Alzheimer's disease (AD). Further, we present the first multi-modal analysis of blood markers in this field. We used blood...
Autores principales: | Voyle, N, Kim, M, Proitsi, P, Ashton, N J, Baird, A L, Bazenet, C, Hye, A, Westwood, S, Chung, R, Ward, M, Rabinovici, G D, Lovestone, S, Breen, G, Legido-Quigley, C, Dobson, R J B, Kiddle, S J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068879/ https://www.ncbi.nlm.nih.gov/pubmed/26812040 http://dx.doi.org/10.1038/tp.2015.205 |
Ejemplares similares
-
Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology
por: Voyle, Nicola, et al.
Publicado: (2015) -
Blood protein predictors of brain amyloid for enrichment in clinical trials?
por: Ashton, Nicholas J., et al.
Publicado: (2015) -
Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid
por: Voyle, Nicola, et al.
Publicado: (2016) -
Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [(18)F]-Flutemetamol PET Scan Result
por: Westwood, Sarah, et al.
Publicado: (2018) -
Plasma protein biomarkers of Alzheimer's disease endophenotypes in asymptomatic older twins: early cognitive decline and regional brain volumes
por: Kiddle, S J, et al.
Publicado: (2015)